Regeneron Pharmaceuticals Stock Target Price and Analyst Consensus

REGN
 Stock
  

USD 596.56  1.16  0.19%   

The current analyst and expert consensus on Regeneron Pharmaceuticals is Buy with 5 hold recommendations. The current projected Regeneron Pharmaceuticals target price consensus is 706.85 with 13 analyst opinions. One of the most common ways Regeneron Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Regeneron Pharmaceuticals vendors, executives, and/or customers. Regeneron Pharmaceuticals recommendation module provides expert sentiment on the projected Regeneron Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 87.013. Additionally, take a look at Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
Gross Profit is expected to rise to about 4.4 B this year. Profit Margin is expected to rise to 54.21 this year. Regeneron Pharmaceuticals Assets Non Current are quite stable at the moment as compared to the past year. The company's current value of Assets Non Current is estimated at 3.68 Billion. Cash and Equivalents is expected to rise to about 3.1 B this year, although the value of Accumulated Other Comprehensive Income will most likely fall to (11.9 M).

Regeneron Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Regeneron target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Regeneron target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions15
Lowered Outlook0
Raized Outlook0
Buy
Most Regeneron analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Regeneron stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Regeneron Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Regeneron Pharmaceuticals Target Price Projection

Regeneron Pharmaceuticals' current and average target prices are 596.56 and 706.85, respectively. The current price of Regeneron Pharmaceuticals is the price at which Regeneron Pharmaceuticals is currently trading. On the other hand, Regeneron Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Regeneron Pharmaceuticals Market Quote on 5th of July 2022

Low Price583.66Odds
High Price597.0Odds

596.56

Target Price

Analyst Consensus On Regeneron Pharmaceuticals Target Price

Low Estimate575.0Odds
High Estimate844.0Odds
Number of Analysts13
Standard Deviation87.013

706.846

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Regeneron Pharmaceuticals and the information provided on this page.

Regeneron Pharmaceuticals Analyst Ratings

Regeneron Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Regeneron Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Regeneron Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Regeneron Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Regeneron Pharmaceuticals Target Price Projections

Regeneron Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Regeneron Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Regeneron depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Regeneron Pharmaceuticals including analysis of its current option contracts.
Regeneron Pharmaceuticals' latest option contracts expiring on 2022-07-15 are carrying combined implied volatility of 23.89 with a put-to-call open interest ratio of 0.58 over 224 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2022-07-15. The current put volume is at 204, with calls trading at the volume of 201. This yields a 1.01 put-to-call volume ratio. The Regeneron Pharmaceuticals option chain provides detailed quote and price information for the current Regeneron Pharmaceuticals option contracts. It shows all of Regeneron Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-07-15 Option Contracts

Regeneron Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Regeneron Pharmaceuticals' lending market. For example, when Regeneron Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Regeneron Pharmaceuticals, he or she must hedge the risk by shorting Regeneron Pharmaceuticals stock over its option's life.
The chart above shows Regeneron Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Regeneron Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Regeneron Pharmaceuticals' option, there is no secondary market available for investors to trade.

Regeneron Pharmaceuticals Maximum Pain Price across 2022-07-15 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Regeneron Pharmaceuticals close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Regeneron Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Regeneron Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Regeneron stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Regeneron Pharmaceuticals' stock price goes up or down, the stock options follow.
Additionally, take a look at Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Regeneron Pharmaceuticals In The Money Call Balance

When Regeneron Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Regeneron Pharmaceuticals stock is said to be in the money. When it comes to buying Regeneron Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Regeneron Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Regeneron Current Options Market Mood

Regeneron Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Regeneron Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Regeneron Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Regeneron Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Regeneron Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Regeneron Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Regeneron Pharmaceuticals is a key component of Regeneron Pharmaceuticals valuation and have some predictive power on the future returns of a Regeneron Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Regeneron Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
593.22595.29597.36
Details
Intrinsic
Valuation
LowReal ValueHigh
536.90663.30665.37
Details
Naive
Forecast
LowNext ValueHigh
663.42665.49667.55
Details
Earnings
Estimates (5)
LowProjected EPSHigh
66.3766.8767.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Regeneron Pharmaceuticals.

Additional Regeneron Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Regeneron Pharmaceuticals is a key component of Regeneron Pharmaceuticals valuation and have some predictive power on the future returns of a Regeneron Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Regeneron Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
593.22595.29597.36
Details
Intrinsic
Valuation
LowReal ValueHigh
536.90663.30665.37
Details
Naive
Forecast
LowNext ValueHigh
663.42665.49667.55
Details
Earnings
Estimates (5)
LowProjected EPSHigh
66.3766.8767.87
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Regeneron Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Cancer Fighters
Invested few shares
Additionally, take a look at Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
The data published in Regeneron Pharmaceuticals' official financial statements usually reflect Regeneron Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Regeneron Pharmaceuticals. For example, before you start analyzing numbers published by Regeneron accountants, it's critical to develop an understanding of what Regeneron Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Regeneron Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Regeneron Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Regeneron Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Regeneron Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Regeneron Pharmaceuticals' management to manipulate its earnings.